Gain Therapeutics GANX
NASDAQ GANX
$1.29 +0.10 (+8.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Gain Therapeutics (GANX) reported Return on Capital Employed [ROCE] of -141.33% for Q2 2026, up 170.47 percentage points from -311.80% a year earlier but down 24.74 percentage points from the prior quarter.

Analysis

Gain Therapeutics (GANX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Gain Therapeutics posted Return on Capital Employed [ROCE] of -132.52%, up 45.13 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a four-year change of -68.93 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -177.65% in FY2024 (-42.00 pp), -135.65% in FY2023 (-70.81 pp), -64.84% in FY2022 (-1.25 pp) and -63.59% in FY2021.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -311.80% in Q2 2025 and a high of -30.29% in Q3 2021.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last three quarters, with an average year-over-year change of +15.96 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2026 (a gain of 180.57 percentage points); the low point was Q3 2023 (a drop of 151.41 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -116.59% (Q1 2026), -138.16% (Q4 2025) and -282.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Gain Therapeutics 55.91 Mn -3.37 Mn - -141.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -141.33%
Mar 31, 2026 -116.59%
Dec 31, 2025 -138.16%
Sep 30, 2025 -282.01%
Jun 30, 2025 -311.80%
Mar 31, 2025 -297.16%
Dec 31, 2024 -218.04%
Sep 30, 2024 -175.83%
Jun 30, 2024 -210.86%
Mar 31, 2024 -184.66%
Dec 31, 2023 -195.14%
Sep 30, 2023 -215.13%
Jun 30, 2023 -156.81%
Mar 31, 2023 -112.32%
Dec 31, 2022 -80.49%
Sep 30, 2022 -63.72%
Jun 30, 2022 -52.05%
Mar 31, 2022 -42.99%
Dec 31, 2021 -36.17%
Sep 30, 2021 -30.29%
API Access

Gain Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GANX&period=max&api_key=YOUR_API_KEY